Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2026-04-30 @ 3:32 AM
Study NCT ID:
NCT06418594
Status:
RECRUITING
Last Update Posted:
2024-12-10
First Post:
2024-05-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis
Sponsor:
Beijing 302 Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MA-BC-II-070
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None